ESC 365 - EHRA PATHS: multimorbidity, polypharmacy and sex differences in atrial fibrillation (AF) patients: unmet needs and how to improve.

Open Access

EHRA PATHS: multimorbidity, polypharmacy and sex differences in atrial fibrillation (AF) patients: unmet needs and how to improve.

Session: The EHRA EU research projects

Topic: European Heart Rhythm Association (EHRA)

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Hein Heidbuchel

University Hospital Antwerp, Antwerp (Belgium)

59 presentations

5 followers

4 more presentations in this session

AFEECT EU: cost benefits and acceptability of atrial fibrillation (AF) screening across different Europe.

Speaker: Professor R. Schnabel (Hamburg, DE)

PROFID: risk score to predict the individual sudden cardiac death (SCD) risk and identify those post-MI patients that will optimally benefit from an implantable cardioverter defibrillator (ICD).

Speaker: Doctor N. Dagres (Berlin, DE)

ESCAPE-NET: towards a personalised risk score for sudden cardiac arrest.

Speaker: Doctor H. Tan (Amsterdam, NL)

The EHRA EU research projects - discussion.

Access the full session

The EHRA EU research projects

Speakers: Professor H. Heidbuchel, Professor R. Schnabel, Doctor N. Dagres, Doctor H. Tan

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources